The Cell Therapy stream explores the critical challenges facing the manufacture, analysis and quality of cell-based therapies. Topics include product and process characterization, CMC strategies, autologous and allogeneic manufacturing strategies, automation, scale-up and supply of CAR Ts and next-generation cell therapies such as NK cells, TILs, iPSCs and TCR-based therapies.

Conferences Include: